Published in Neurology on July 26, 2013
New-onset refractory status epilepticus: Etiology, clinical features, and outcome. Neurology (2015) 0.94
Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010. PLoS One (2014) 0.90
Long-term outcome of severe herpes simplex encephalitis: a population-based observational study. Crit Care (2015) 0.81
Neuroinfectious diseases: a crisis in neurology and a call for action. JAMA Neurol (2015) 0.81
Clinical characteristics and outcome of clinically diagnosed viral encephalitis in southwest China. Neurol Sci (2015) 0.79
Nonconvulsive status epilepticus in adults - insights into the invisible. Nat Rev Neurol (2016) 0.78
Autoimmune Encephalitis at the Neurological Intensive Care Unit: Etiologies, Reasons for Admission and Survival. Neurocrit Care (2016) 0.77
Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management. Neurotherapeutics (2016) 0.77
Influence of malnutrition on adverse outcome in children with confirmed or probable viral encephalitis: a prospective observational study. Biomed Res Int (2015) 0.75
Early-onset status epilepticus in patients with acute encephalitis. Medicine (Baltimore) (2016) 0.75
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol (2013) 11.47
Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J (1957) 8.43
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis (2010) 7.60
Status epilepticus. N Engl J Med (1998) 5.52
The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2008) 3.79
Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol (2002) 3.36
An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer (2004) 3.06
Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis (2010) 3.00
In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis (2003) 2.99
Infectious encephalitis in france in 2007: a national prospective study. Clin Infect Dis (2009) 2.96
Acute disseminated encephalomyelitis. Neurology (2007) 2.84
Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis (2002) 2.71
Reversal of transtentorial herniation with hypertonic saline. Neurology (2008) 2.65
Thrombocytopenia and prognosis in intensive care. Crit Care Med (2000) 2.26
Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis (1995) 2.18
Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med (2002) 2.18
Neuroimaging of herpesvirus infections in children. Pediatr Radiol (2007) 2.13
Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry (2005) 2.13
[Decompressive craniectomy in acute encephalitis]. Tidsskr Nor Laegeforen (2006) 2.05
Coagulation abnormalities in critically ill patients. Crit Care (2006) 1.84
Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology (2000) 1.49
Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia (2001) 1.49
Short-term mortality after a first episode of status epilepticus. Epilepsia (1997) 1.49
Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry (2005) 1.36
Challenge of the unknown. A systematic review of acute encephalitis in non-outbreak situations. Neurology (2010) 1.33
Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia (2003) 1.29
Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol (2010) 1.03
Emergency decompressive craniectomy for fulminating infectious encephalitis. J Neurosurg (2008) 0.98
Thrombocytopenic disorders in critically ill patients. Am J Respir Crit Care Med (2000) 0.90
Decompressive hemicraniectomy for acute disseminated encephalomyelitis: case report. Neurosurgery (2005) 0.89
Intracranial pressure and outcome in adult encephalitis. J Neurosurg (1988) 0.89
Herpes simplex encephalitis: the role of surgical decompression. Surg Neurol (2002) 0.85
[Decompressive craniectomy in a patient with herpetic encephalitis associated to refractory intracranial hypertension]. Rev Med Chil (2003) 0.84
[Decompressive craniectomy for severe intracranial hypertension due to cerebral infarction or meningoencephalitis]. Anasthesiol Intensivmed Notfallmed Schmerzther (2002) 0.82
Status epilepticus in encephalitis: a study of clinical findings, magnetic resonance imaging, and response to antiepileptic drugs. J Neurovirol (2008) 0.78
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol (2008) 6.91
Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2010) 6.01
The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS (2007) 5.18
The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48
HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol (2002) 4.20
Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol (2010) 2.91
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS (2009) 2.88
Awakening and withdrawal of life-sustaining treatment in cardiac arrest survivors treated with therapeutic hypothermia*. Crit Care Med (2014) 2.73
Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised. Neurology (2012) 2.30
Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol (2006) 2.27
A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin Infect Dis (2005) 2.25
Falling temperature and colder weather are associated with an increased risk of aneurysmal subarachnoid hemorrhage. World Neurosurg (2012) 2.20
Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation (2015) 2.16
Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol (2009) 2.14
"Any possible restoration of function could not occur": Harvey Cushing and the early description of brain death. World Neurosurg (2011) 2.03
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol (2007) 1.94
Primary outcomes for resuscitation science studies: a consensus statement from the American Heart Association. Circulation (2011) 1.93
Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. Neurology (2012) 1.91
The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain (2004) 1.90
Early electrophysiologic markers predict functional outcome associated with temperature manipulation after cardiac arrest in rats. Crit Care Med (2008) 1.89
Patient flow variability and unplanned readmissions to an intensive care unit. Crit Care Med (2009) 1.88
Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann Neurol (2004) 1.87
Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz. J Pharmacol Exp Ther (2012) 1.79
Association between hospitals caring for a disproportionately high percentage of minority trauma patients and increased mortality: a nationwide analysis of 434 hospitals. Arch Surg (2011) 1.77
Neurologic recovery after therapeutic hypothermia in patients with post-cardiac arrest myoclonus. Resuscitation (2011) 1.68
Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS (2002) 1.68
Quantitative assessment of somatosensory-evoked potentials after cardiac arrest in rats: prognostication of functional outcomes. Crit Care Med (2010) 1.66
HIV-associated sensory neuropathies. AIDS (2002) 1.65
Evaluating sleep and cognition in HIV. J Acquir Immune Defic Syndr (2013) 1.64
Development and validation of the Good Outcome Following Attempted Resuscitation (GO-FAR) score to predict neurologically intact survival after in-hospital cardiopulmonary resuscitation. JAMA Intern Med (2013) 1.62
A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology (2013) 1.62
Influence of the National Trauma Data Bank on the study of trauma outcomes: is it time to set research best practices to further enhance its impact? J Am Coll Surg (2012) 1.61
Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med (2012) 1.60
Evolution of Somatosensory Evoked Potentials after Cardiac Arrest induced hypoxic-ischemic injury. Resuscitation (2010) 1.58
Evolution of HIV dementia with HIV infection. Int Rev Psychiatry (2008) 1.58
Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol (2011) 1.57
Clinical validation of the NeuroScreen. J Neurovirol (2005) 1.57
Assessing HIV-associated dementia: modified HIV dementia scale versus the Grooved Pegboard. AIDS Read (2002) 1.56
HIV-associated neurocognitive disorders: is there a hidden epidemic? AIDS (2010) 1.56
Peripheral neuropathy in HIV: prevalence and risk factors. AIDS (2011) 1.53
Ketogenic diet for adults in super-refractory status epilepticus. Neurology (2014) 1.49
Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology (2004) 1.49
Older patients with diverticulitis have low recurrence rates and rarely need surgery. Surgery (2011) 1.48
Diagnostic utility of the subjective peripheral neuropathy screen in HIV-infected persons with peripheral sensory polyneuropathy. AIDS Read (2005) 1.46
Prediction of survival to discharge following cardiopulmonary resuscitation using classification and regression trees. Crit Care Med (2013) 1.45
Low atazanavir concentrations in cerebrospinal fluid. AIDS (2009) 1.45
Improving neurological outcomes post-cardiac arrest in a rat model: immediate hypothermia and quantitative EEG monitoring. Resuscitation (2007) 1.44
Cerebral herniation associated with central venous catheter insertion: risk assessment. J Crit Care (2012) 1.44
Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: correlation with [11C-methyl]thymidine PET and thallium-201 SPECT. Acad Radiol (2002) 1.43
The impact of molecular testing on the surgical management of patients with thyroid nodules. Ann Surg Oncol (2014) 1.43
Quantitative EEG and neurological recovery with therapeutic hypothermia after asphyxial cardiac arrest in rats. Brain Res (2006) 1.41
Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1. J Virol (2008) 1.40
BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis. J Clin Endocrinol Metab (2012) 1.39
Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol (2003) 1.39
No endovascular innovation without evaluation in chronic cerebrospinal venous insufficiency: a call for the IDEAL model. Arch Neurol (2011) 1.39
Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology (2005) 1.39
Quantitative EEG and effect of hypothermia on brain recovery after cardiac arrest. IEEE Trans Biomed Eng (2006) 1.34
Cdk5 is essential for adult hippocampal neurogenesis. Proc Natl Acad Sci U S A (2008) 1.34
Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. J Neurovirol (2006) 1.33
Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. J Acquir Immune Defic Syndr (2005) 1.32
Blood-pressure lowering in acute intracerebral hemorrhage. N Engl J Med (2013) 1.27
Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS. J Neurovirol (2005) 1.23
HIV-associated opportunistic infections of the CNS. Lancet Neurol (2012) 1.22
Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsies. Brain (2007) 1.21
Sleep, function and HIV: a multi-method assessment. AIDS Behav (2013) 1.20
Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med (2015) 1.18
The burden of acute traumatic spinal cord injury among adults in the united states: an update. J Neurotrauma (2014) 1.16
Assessment of epidermal nerve fibers: a new diagnostic and predictive tool for peripheral neuropathies. J Neuropathol Exp Neurol (2007) 1.15
Duplex ultrasound screening for deep vein thrombosis in asymptomatic trauma patients: a survey of individual trauma surgeon opinions and current trauma center practices. J Trauma (2011) 1.13
Limitations of administrative databases. JAMA (2012) 1.12
Saving the clinician-scientist: report of the ANA long range planning committee. Ann Neurol (2006) 1.12
Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy. J Neuroimmunol (2011) 1.12
Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production. Ann Neurol (2002) 1.11
Nucleoside analogues and neuropathy in the era of HAART. J Clin Virol (2003) 1.11
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis. Arch Neurol (2008) 1.10
Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch Neurol (2009) 1.09
Post-cardiac arrest temperature manipulation alters early EEG bursting in rats. Resuscitation (2008) 1.09
Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat. J Acquir Immune Defic Syndr (2002) 1.09
Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol (2008) 1.08
Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals. J Acquir Immune Defic Syndr (2006) 1.08
Epidermal reinnervation after intracutaneous axotomy in man. J Comp Neurol (2003) 1.08
Depressive symptoms, quality of life, and neuropsychological performance in HIV/AIDS: the impact of gender and injection drug use. J Neurovirol (2005) 1.08
Peripheral nerve-derived HIV-1 is predominantly CCR5-dependent and causes neuronal degeneration and neuroinflammation. Virology (2005) 1.07
Predictors of positive head CT scan and neurosurgical procedures after minor head trauma. J Surg Res (2011) 1.07
Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus -associated dementia. Arch Neurol (2007) 1.06
Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl. Neurobiol Dis (2006) 1.06
Toll/interleukin-1 receptor domain-containing adapter inducing interferon-β mediates microglial phagocytosis of degenerating axons. J Neurosci (2012) 1.05
Impaired neurovascular repair in subjects with diabetes following experimental intracutaneous axotomy. Brain (2011) 1.05
Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart Association. Circulation (2013) 1.04
Oxidative stress and therapeutic approaches in HIV dementia. Antioxid Redox Signal (2006) 1.04
Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. J Immunol (2005) 1.04
Needle type and the risk of post-lumbar puncture headache in the outpatient neurology clinic. J Neurol Sci (2011) 1.02
Circular compartmentalized microfluidic platform: Study of axon-glia interactions. Lab Chip (2010) 1.02
HIV-associated neurological disorders: a guide to pharmacotherapy. CNS Drugs (2012) 1.01
Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome. Arch Neurol (2006) 1.01